TMAPX
Price
$58.61
Change
+$0.45 (+0.77%)
Updated
Aug 19 closing price
Net Assets
3.51B
VEXMX
Price
$187.02
Change
+$0.45 (+0.24%)
Updated
Aug 19 closing price
Net Assets
93.63B
Interact to see
Advertisement

TMAPX vs VEXMX

TMAPX vs VEXMX Comparison Chart in %
View a ticker or compare two or three
VS
TMAPX vs. VEXMX commentary
Aug 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMAPX is a Hold and VEXMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 93.6B vs. TMAPX (3.51B). VEXMX pays higher dividends than TMAPX: VEXMX (0.90) vs TMAPX (0.01). TMAPX was incepted earlier than VEXMX: TMAPX (19 years) vs VEXMX (39 years). TMAPX (1.18) is less costly to investors than VEXMX (0.19). TMAPX (12.00) and VEXMX (12.00) have comparable annual turnover. TMAPX has a lower initial minimum investment than VEXMX: TMAPX (2500) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 23.61 vs. TMAPX (4.54). VEXMX return over 5 years is better than : 36.08 vs. TMAPX (23.26).
TMAPXVEXMXTMAPX / VEXMX
Total Expense Ratio1.180.19621%
Annual Report Gross Expense Ratio1.180.19621%
Fund Existence19 years39 years-
Gain YTD4.69817.68227%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets3.51B93.6B4%
Annual Yield % from dividends0.010.901%
Returns for 1 year4.5423.6119%
Returns for 3 years23.8369.4334%
Returns for 5 years23.2636.0864%
Returns for 10 years120.80180.1567%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNTA1.220.05
+4.27%
Genenta Science SpA
STOK33.030.89
+2.77%
Stoke Therapeutics
FCNCO20.700.17
+0.83%
First Citizens BancShares
ENSG182.49N/A
N/A
Ensign Group (The)
CYH2.92-0.06
-2.01%
Community Health Systems